Dose-ranging study of lebrikizumab in asthmatic patients not receiving inhaled steroids  Michael Noonan, MD, Phillip Korenblat, MD, Sofia Mosesova, PhD,

Slides:



Advertisements
Similar presentations
Joint modeling of parentally reported and physician-confirmed wheeze identifies children with persistent troublesome wheezing Danielle C.M. Belgrave, MSc,
Advertisements

A bioinformatics approach to identify patients with symptomatic peanut allergy using peptide microarray immunoassay Jing Lin, PhD, Francesca M. Bruni,
Early exposure to cow's milk protein is protective against IgE-mediated cow's milk protein allergy Yitzhak Katz, MD, Nelly Rajuan, MSc, Michael R. Goldberg,
Control of immunopathology during chikungunya virus infection Caroline Petitdemange, PhD, Nadia Wauquier, PhD, Vincent Vieillard, PhD Journal of Allergy.
Endoplasmic reticulum stress influences bronchial asthma pathogenesis by modulating nuclear factor κB activation So Ri Kim, MD, PhD, Dong Im Kim, MS, Mi.
D-dimer: A biomarker for antihistamine-resistant chronic urticaria
Jonathan A. Bernstein, MD, David M. Lang, MD, David A. Khan, MD 
Clarification concerning amoxicillin skin testing
Alalia Berry, MD, William W. Busse, MD 
Chlamydophila (Chlamydia) pneumoniae serology and asthma in adults: A longitudinal analysis  Rafael Pasternack, MD, PhD, Heini Huhtala, MSc, Jussi Karjalainen,
Santa Jeremy Ono, BA, PhD, Mark B. Abelson, MD 
Stephen J. Fowler, MD, Gaël Tavernier, PhD, Robert Niven, MD 
Longitudinal variation of serum periostin levels in adults with stable asthma  Ruth Semprini, MB BS, Rachel Caswell-Smith, MBChB, James Fingleton, PhD,
Dorothy M. Ryan, MD, Stephen J. Fowler, MD, Robert M. Niven, MD 
Is 9 more than 2 also in allergic airway inflammation?
Desensitization to Chemotherapeutic Agents
Jonathan A. Bernstein, MD, David M. Lang, MD, David A. Khan, MD 
Badrul A. Chowdhury, MD, PhD 
An Infant with Atopic Dermatitis and Itching After Ingestion of Milk
Serum periostin is associated with type 2 immunity in severe asthma
Mothers' anxiety during pregnancy is associated with asthma in their children  Hannah Cookson, MB, ChB, Raquel Granell, PhD, Carol Joinson, PhD, Yoav Ben-Shlomo,
Functional FCGR2B gene variants influence intravenous immunoglobulin response in patients with Kawasaki disease  Sadeep Shrestha, PhD, Howard W. Wiener,
David F. Choy, BS, Guiquan Jia, MD, Alexander R. Abbas, PhD, Katrina B
Lieuwe D. Bos, MSc, PhD, Peter J. Sterk, MD, PhD, Stephen J
Allergy testing in predicting outcome of open food challenge to peanut
Safety and efficacy of the prostaglandin D2 receptor antagonist AMG 853 in asthmatic patients  William W. Busse, MD, Sally E. Wenzel, MD, Eli O. Meltzer,
The risk of asthma exacerbation after stopping low-dose inhaled corticosteroids: A systematic review and meta-analysis of randomized controlled trials 
Clinical studies of the DP1 antagonist laropiprant in asthma and allergic rhinitis  George Philip, MD, Janet van Adelsberg, MD, Thomas Loeys, PhD, Nancy.
Physician needs in health informatics: Just ask the docs
Treatment of chronic autoimmune urticaria with omalizumab
A randomized, placebo-controlled, dose-ranging study of single-dose omalizumab in patients with H1-antihistamine–refractory chronic idiopathic urticaria 
Nonadherence to Asthma Treatment: Getting Unstuck
Peter M. Wolfgram, MD, David B. Allen, MD 
Jewlya Lynn, PhD, Sophie Oppenheimer, MS, MPH, Lorena Zimmer, MA 
Repeated Episodes of Anaphylaxis with Normal Serum Tryptase but Elevated Levels of Urinary Prostaglandin D2  Phillip Lieberman, MD  The Journal of Allergy.
Cats and dogs and the risk of atopy in childhood and adulthood
Debra J. Palmer, PhD, Thomas R. Sullivan, BMa&CompSc(Hons), Michael S
Risk of congenital malformations for asthmatic pregnant women using a long-acting β2- agonist and inhaled corticosteroid combination versus higher-dose.
Phillip Lieberman, MD, Michael Tankersley, MD 
High eosinophil count: A potential biomarker for assessing successful omalizumab treatment effects  William Busse, MD, Sheldon Spector, MD, Karin Rosén,
Time for a paradigm shift in asthma treatment: From relieving bronchospasm to controlling systemic inflammation  Leif Bjermer, MD  Journal of Allergy.
Ovalbumin content of influenza vaccines
Food allergy: A review and update on epidemiology, pathogenesis, diagnosis, prevention, and management  Scott H. Sicherer, MD, Hugh A. Sampson, MD  Journal.
Biosimilars and drug development in allergic and immunologic diseases
Nicola A. Hanania, MB BS, MS, Bradley E. Chipps, MD, Noelle M
A cluster-randomized trial shows telephone peer coaching for parents reduces children's asthma morbidity  Jane M. Garbutt, MB, ChB, Yan Yan, MD, PhD,
Claus Bachert, MD, PhD, Cezmi A. Akdis, MD 
Budesonide delivered by Turbuhaler is effective in a dose-dependent fashion when used in the treatment of adult patients with chronic asthma  William.
What is an “eosinophilic phenotype” of asthma?
Jeffrey M. Harris, MD, PhD, Christopher R
Granulomatous-lymphocytic Interstitial Lung Disease in a Patient with Common Variable Immunodeficiency  Phil Lieberman, MD, John Routes, MD  The Journal.
H. William Kelly, PharmD  Journal of Allergy and Clinical Immunology 
Autophagy: Nobel Prize 2016 and allergy and asthma research
Food allergy: Epidemiology, pathogenesis, diagnosis, and treatment
Advances in the approach to the patient with food allergy
Geographic variability in childhood asthma prevalence in Chicago
A single intervention for cockroach control reduces cockroach exposure and asthma morbidity in children  Felicia A. Rabito, PhD, MPH, John C. Carlson,
Syk expression and IgE-mediated histamine release in basophils as biomarkers for predicting the clinical efficacy of omalizumab  Donald W. MacGlashan,
John Leung, MD, Navneet Virk Hundal, MD, Aubrey J. Katz, MD, Wayne G
Risk of oral food challenges
Benjamin Chaigne, MD, Hervé Watier, MD, PhD 
Pınar Uysal, MD, Esben Eller, MSc, PhD, Charlotte G
Macrolide antibiotics and asthma treatment
Asthma: The past, future, environment, and costs
Interrupting IL-6–receptor signaling improves atopic dermatitis but associates with bacterial superinfection  Alexander A. Navarini, MD, PhD, Lars E.
Environmental factors and eosinophilic esophagitis
Safety and efficacy of repeated monthly carboplatin desensitization
Effect of codeine on objective measurement of cough in chronic obstructive pulmonary disease  Jaclyn Smith, MD, PhD, Emily Owen, MPhil, John Earis, MD,
Natural history of cow’s milk allergy
Primary prevention of asthma and allergy
Presentation transcript:

Dose-ranging study of lebrikizumab in asthmatic patients not receiving inhaled steroids  Michael Noonan, MD, Phillip Korenblat, MD, Sofia Mosesova, PhD, Heleen Scheerens, PhD, Joseph R. Arron, MD, PhD, Yanan Zheng, PhD, Wendy S. Putnam, PhD, Merdad V. Parsey, MD, PhD, Sean P. Bohen, MD, PhD, John G. Matthews, MB, BS, PhD  Journal of Allergy and Clinical Immunology  Volume 132, Issue 3, Pages 567-574.e12 (September 2013) DOI: 10.1016/j.jaci.2013.03.051 Copyright © 2013 American Academy of Allergy, Asthma & Immunology Terms and Conditions

Fig 1 Patient disposition. Journal of Allergy and Clinical Immunology 2013 132, 567-574.e12DOI: (10.1016/j.jaci.2013.03.051) Copyright © 2013 American Academy of Allergy, Asthma & Immunology Terms and Conditions

Fig 2 Percentage change in FEV1 from baseline to week 20: (A) mITT; (B) periostin-high patients; and (C) periostin-low patients. Journal of Allergy and Clinical Immunology 2013 132, 567-574.e12DOI: (10.1016/j.jaci.2013.03.051) Copyright © 2013 American Academy of Allergy, Asthma & Immunology Terms and Conditions

Fig 3 Kaplan–Meier plots of time to treatment failure: (A) mITT; (B) periostin-high patients; and (C) periostin-low patients. Journal of Allergy and Clinical Immunology 2013 132, 567-574.e12DOI: (10.1016/j.jaci.2013.03.051) Copyright © 2013 American Academy of Allergy, Asthma & Immunology Terms and Conditions

Fig E1 Percentage change in PEF from baseline to week 20: (A) mITT; (B) periostin-high patients; and (C) periostin-low patients. Journal of Allergy and Clinical Immunology 2013 132, 567-574.e12DOI: (10.1016/j.jaci.2013.03.051) Copyright © 2013 American Academy of Allergy, Asthma & Immunology Terms and Conditions

Fig E2 Median values of pharmacodynamic biomarkers during the study. Journal of Allergy and Clinical Immunology 2013 132, 567-574.e12DOI: (10.1016/j.jaci.2013.03.051) Copyright © 2013 American Academy of Allergy, Asthma & Immunology Terms and Conditions

Fig E3 Median change from baseline of pharmacodynamic biomarkers after treatment. Journal of Allergy and Clinical Immunology 2013 132, 567-574.e12DOI: (10.1016/j.jaci.2013.03.051) Copyright © 2013 American Academy of Allergy, Asthma & Immunology Terms and Conditions